MetLife Investment Management’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$209K Buy
+32,682
New +$209K ﹤0.01% 2165
2024
Q3
Hold
0
2868
2024
Q2
Hold
0
2894
2024
Q1
Sell
-27,395
Closed -$65.7K 2794
2023
Q4
$65.7K Hold
27,395
﹤0.01% 2749
2023
Q3
$93.1K Hold
27,395
﹤0.01% 2616
2023
Q2
$201K Hold
27,395
﹤0.01% 2274
2023
Q1
$284K Hold
27,395
﹤0.01% 2001
2022
Q4
$324K Hold
27,395
﹤0.01% 1919
2022
Q3
$575K Hold
27,395
﹤0.01% 1535
2022
Q2
$850K Hold
27,395
0.01% 1295
2022
Q1
$1.12M Buy
27,395
+9,797
+56% +$402K 0.01% 1258
2021
Q4
$765K Sell
17,598
-22,960
-57% -$998K 0.01% 1254
2021
Q3
$2.03M Buy
40,558
+201
+0.5% +$10.1K 0.02% 851
2021
Q2
$2.54M Sell
40,357
-643
-2% -$40.5K 0.02% 766
2021
Q1
$3.81M Sell
41,000
-2,365
-5% -$220K 0.03% 535
2020
Q4
$3.89M Sell
43,365
-1,105
-2% -$99K 0.04% 480
2020
Q3
$4.6M Buy
44,470
+24,459
+122% +$2.53M 0.05% 341
2020
Q2
$1.58M Hold
20,011
0.02% 827
2020
Q1
$1.16M Hold
20,011
0.02% 838
2019
Q4
$1.08M Hold
20,011
0.01% 1063
2019
Q3
$1.05M Hold
20,011
0.01% 1044
2019
Q2
$967K Hold
20,011
0.01% 1118
2019
Q1
$1.01M Hold
20,011
0.01% 1079
2018
Q4
$1.19M Buy
20,011
+1,170
+6% +$69.4K 0.01% 957
2018
Q3
$1.24M Sell
18,841
-1,671
-8% -$110K 0.01% 1035
2018
Q2
$1.04M Buy
20,512
+4,795
+31% +$242K 0.01% 1005
2018
Q1
$828K Hold
15,717
0.01% 1093
2017
Q4
$730K Buy
+15,717
New +$730K 0.01% 1182